CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −233 | 114,954 | ||
| 2026-05-04 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +4,517 | $12.95 | $58K | 4,517 |
| 2026-05-04 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −4,517 | $227.94 | $1.0M | 0 |
| 2026-05-04 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,517 | 115,187 | ||
| 2026-04-22 | Maizel Ari Chief Commercial Officer | Option exercise 10b5-1 | +7,500 | $70.73 | $530K | 7,500 |
| 2026-04-22 | Maizel Ari Chief Commercial Officer | Sale 10b5-1 | −7,500 | $182.42 | $1.4M | 0 |
| 2026-04-22 | Maizel Ari Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 23,710 | ||
| 2026-04-21 | Jacobson Mark L. Chief Operating Officer | Grant or award · Performance Stock Units | +8,669 | 8,669 | ||
| 2026-04-21 | TABUTEAU HERRIOT Chief Executive Officer | Grant or award · Performance Stock Units | +24,081 | 24,081 | ||
| 2026-04-21 | Maizel Ari Chief Commercial Officer | Grant or award · Performance Stock Units | +7,224 | 7,224 | ||
| 2026-04-21 | Pizzie Nick Chief Financial Officer | Grant or award · Performance Stock Units | +8,188 | 8,188 | ||
| 2026-04-21 | Murdock Hunter R. General Counsel | Grant or award · Performance Stock Units | +7,224 | 7,224 | ||
| 2026-02-26 | TABUTEAU HERRIOT Chief Executive Officer | Grant or award · Restricted Stock Units | +54,623 | 54,623 | ||
| 2026-02-26 | Pizzie Nick Chief Financial Officer | Grant or award · Restricted Stock Units | +18,570 | 18,570 | ||
| 2026-02-26 | Murdock Hunter R. General Counsel | Grant or award · Restricted Stock Units | +16,385 | 16,385 | ||
| 2026-02-26 | Maizel Ari Chief Commercial Officer | Grant or award · Restricted Stock Units | +16,385 | 16,385 | ||
| 2026-02-26 | Jacobson Mark L. Chief Operating Officer | Grant or award · Restricted Stock Units | +19,663 | 19,663 | ||
| 2026-02-26 | Coleman Mark Director | Sale 10b5-1 | −25,000 | $161.11 | $4.0M | 47,140 |
| 2026-02-26 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +35,378 | $2.85 | $101K | 35,378 |
| 2026-02-26 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −35,378 | $161.88 | $5.7M | 0 |
Page 3 of 22 · 422 trades